Wang Y , Yang E , Wells MM , Bondarenko V , Woll K , Carnevale V , Granata D , Klein ML , Eckenhoff RG , Dailey WP , Covarrubias M , Tang P , Xu Y .

F30 GM123612 NIGMS NIH HHS , P01 GM055876 NIGMS NIH HHS , R01 GM049202 NIGMS NIH HHS , R01 GM056257 NIGMS NIH HHS

	Figure 1. In vivo anesthetizing concentrations of propofol and 4-fluoropropofol in albino X. laevis tadpoles are identical. The percentage of immobilized tadpoles is plotted as a function of propofol and 4-fluoropropofol concentrations. The solid lines are best fit to the data by using Eq. 4. Error bars show the SEMs from three independent measurements with 10 tadpoles per measurement at each drug concentration.
	Figure 2. 4-Fluoropropofol modulates voltage-dependent activation and inactivation of NaChBac. (A) Representative paired current families in the absence (control) and presence of 4 µM 4-fluoropropofol. (B) Paired currents at +20 mV. The 4-µM 4-fluoropropofol trace is shown scaled to its respective control Ipeak. The 40-µM 4-fluoropropofol trace is shown both as a raw current and scaled to its respective control Ipeak. (C) Time constants of inactivation (τ) versus voltage of control (n = 20) and 4-fluoropropofol at 4 and 40 µM (n = 8–12). 4-Fluoropropofol reduced τInactivation at both concentrations and all voltages (P < 0.0001, paired t test). (D and E) Normalized G-V (D) and prepulse (E) inactivation curves of control and 4-fluoropropofol at the indicated concentrations (n = 5–12). Corresponding midpoints (V1/2) of activation and inactivation are shown below the corresponding curves. Means are indicated in magenta. Data are reported as mean ± SEM from n independent measurements.
	Figure 3. In silico predicted propofol binding sites in NaChBac. (A) Top and side views of a NaChBac structure model with putative propofol binding sites identified by molecular docking (cyan spheres, occupancy ≥ 10%). (B and C) Zoomed-in views of the lowest energy conformation from docking calculations of propofol (cyan) bound to NaChBac inside the pore at the selectivity filter (B) and above the activation gate (C). Residues in close proximity to the docked propofol are shown as sticks labeled with the corresponding color. Note that residues selected for 19F labeling in STD NMR experiments (T189, I223, F227) are within the binding sites but unlikely to be essential for propofol binding to these regions. (D) Top and side views of NaChBac from the final frame of the 1-µs flooding MD simulation with putative propofol-binding sites (cyan spheres, occupancy ≥ 90%). (E and F) Zoomed-in views of propofol bound to NaChBac in the final frame of the 1-µs flooding MD simulation in the apex of the voltage-sensing domain (E) and an intersubunit site at the intracellular interface (F). Residues in close proximity to the docked propofol are shown as sticks labeled with the corresponding color. Note that residues selected for 19F labeling in STD NMR experiments (N36, V40, S129, L150) are within the binding sites but unlikely to be essential for propofol binding to these regions.
	Figure 4. Effects of single-cysteine mutations on NaChBac modulation by 4-fluoropropofol. (A) Paired G-V and prepulse inactivation curves without (black) and with (light blue) 4 µM 4-fluoropropofol (n = 4–13) for WT and each NaChBac mutant. (B and C) ΔV1/2 values of activation (B) and inactivation (C) induced by 4 µM 4-fluoropropofol for WT and NaChBac mutants. The ΔV1/2 values of activation were not significantly different between WT and the mutants. Of the four mutants, only S129C shows significantly different ΔV1/2 of inactivation from the WT (P = 0.0384, one-way ANOVA with Bonferroni post hoc correction). (D) Fold-change in time constants (τ) of inactivation (τ4-fluoropropofol/τcontrol) at +20 mV induced by 4 µM 4-fluoropropofol. Time constants were derived from the decaying phase of the Na+ currents, which were well described by the single exponential function. For all mutants, the fold-change in τInactivation caused by 4 µM 4-fluoropropofol was not significantly different from that of WT (one-way ANOVA with Bonferroni post hoc correction). Data are reported as mean ± SEM from n independent measurements.
	Figure 5. 19F-NMR measurements of 4-fluoropropofol binding to NaChBac. (A) Representative 19F-NMR spectra of the BTFA-labeled S129C NaChBac mutant in the presence of 200 µM 4-fluoropropofol with selective on- (black, Ion) and off-resonance (red, Ioff) saturation of the BTFA peak. The saturation time was 2 s. (B) Stack plot of 19F STD NMR spectra showing that 4-fluoropropofol interacts specifically with the BTFA labeled at S129C for intermolecular saturation transfer to be built up at longer saturation time (τ). (C) Stack plot of 19F STD NMR spectra showing that 4-fluoropropofol has no measurable interaction with the negative control BTFA-labeled S208C NaChBac.
	Figure 6. Quantitative analysis of 19F NMR STD build-up from individual mutation sites in NaChBac to 4-fluoropropofol. Mutations are grouped by four regions: (A) the extracellular interface (S208), (B) the S4–S5 linker region (L150C, S129C), (C) the apex of the voltage sensing domain (N36C, V40C), and (D) the pore region (F227C, I223, T189C). The solid lines are the best fit to the data by using the two-parameter equation (Eq. 1), yielding the cross-relaxation rate constant and the saturating magnetization transfer from the 19F labels on NaChBac to 4-fluoropropofol. Error bars are uncertainties calculated from the root-mean-squared noise-to-signal ratios in the on- and off-resonance 19F NMR spectra.
	Figure 7. Local anesthetic inhibition of 4-fluoropropofol 19F NMR STD signal in the pore of NaChBac. (A and B) Stack plots of 19F STD NMR spectra for 100 µM 4-fluoropropofol interacting with the BTFA labeled at I223C in the absence (A) and presence (B) of 50 µM etidocaine, a local anesthetic. (C) 19F NMR STD accumulation in the absence (black) and presence (red) of 50 µM etidocaine. The solid lines are the best fit to the data by using the two-parameter equation (Eq. 1), yielding the cross-relaxation rate constant and the saturating magnetization transfer from the 19F labels on I223C in NaChBac to 4-fluoropropofol. Error bars are uncertainties calculated from the root-mean-square noise-to-signal ratios in the on- and off-resonance 19F NMR spectra.

Amarouch, Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels. 2015, Pubmed

Amarouch, Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels. 2015, Pubmed
Angulo, Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates. 2010, Pubmed
Barber, Hinge-bending motions in the pore domain of a bacterial voltage-gated sodium channel. 2012, Pubmed
Barber, Modulation of a voltage-gated Na+ channel by sevoflurane involves multiple sites and distinct mechanisms. 2014, Pubmed
Boiteux, Local anesthetic and antiepileptic drug access and binding to a bacterial voltage-gated sodium channel. 2014, Pubmed
Bondarenko, NMR structures of the human α7 nAChR transmembrane domain and associated anesthetic binding sites. 2014, Pubmed , Xenbase
Chan, A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties. 2018, Pubmed
Chen, Anesthetic binding in a pentameric ligand-gated ion channel: GLIC. 2010, Pubmed
Danielson, Use of 19F NMR to probe protein structure and conformational changes. 1996, Pubmed
Eckenhoff, Molecular interactions between inhaled anesthetics and proteins. 1997, Pubmed
Frenkel, Human brain sodium channels as one of the molecular target sites for the new intravenous anaesthetic propofol (2,6-diisopropylphenol). 1991, Pubmed
Goldschen-Ohm, Probing gating mechanisms of sodium channels using pore blockers. 2014, Pubmed
Habib, Sodium channels and pain. 2015, Pubmed
Haeseler, High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. 2008, Pubmed
Haeseler, High-affinity block of voltage-operated rat IIA neuronal sodium channels by 2,6 di-tert-butylphenol, a propofol analogue. 2003, Pubmed
Hall, m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol. 2010, Pubmed , Xenbase
Hemmings, Emerging molecular mechanisms of general anesthetic action. 2005, Pubmed
Hénin, United-atom acyl chains for CHARMM phospholipids. 2008, Pubmed
Jayalakshmi, Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes. 2002, Pubmed
Jayalakshmi, CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities. 2004, Pubmed
Jeevaratnam, Sodium channel haploinsufficiency and structural change in ventricular arrhythmogenesis. 2016, Pubmed
Khan, Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment. 2014, Pubmed
Kinde, Fluorine-19 NMR and computational quantification of isoflurane binding to the voltage-gated sodium channel NaChBac. 2016, Pubmed
Künze, Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy. 2016, Pubmed
Künze, NMR characterization of the binding properties and conformation of glycosaminoglycans interacting with interleukin-10. 2014, Pubmed
LeBard, General anesthetics predicted to block the GLIC pore with micromolar affinity. 2012, Pubmed
Lee, CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. 2016, Pubmed
Lenaeus, Structures of closed and open states of a voltage-gated sodium channel. 2017, Pubmed
Lepre, Theory and applications of NMR-based screening in pharmaceutical research. 2004, Pubmed
Lin, Regulation of membrane excitability: a convergence on voltage-gated sodium conductance. 2015, Pubmed
Liu, General anesthetic binding to neuronal alpha4beta2 nicotinic acetylcholine receptor and its effects on global dynamics. 2009, Pubmed
Mayer, Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. 1999, Pubmed
Morris, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. 2009, Pubmed
Mowrey, Insights into distinct modulation of α7 and α7β2 nicotinic acetylcholine receptors by the volatile anesthetic isoflurane. 2013, Pubmed
Ouyang, Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. 2003, Pubmed
OuYang, Isoform-selective effects of isoflurane on voltage-gated Na+ channels. 2007, Pubmed
Pan, Structure of the pentameric ligand-gated ion channel GLIC bound with anesthetic ketamine. 2012, Pubmed , Xenbase
Pavlov, The pore, not cytoplasmic domains, underlies inactivation in a prokaryotic sodium channel. 2005, Pubmed
Payandeh, The crystal structure of a voltage-gated sodium channel. 2011, Pubmed
Phillips, Scalable molecular dynamics with NAMD. 2005, Pubmed
Purtell, Activity-dependent depression of neuronal sodium channels by the general anaesthetic isoflurane. 2015, Pubmed
Ragsdale, Molecular determinants of state-dependent block of Na+ channels by local anesthetics. 1994, Pubmed , Xenbase
Rehberg, Suppression of central nervous system sodium channels by propofol. 1999, Pubmed
Ren, A prokaryotic voltage-gated sodium channel. 2001, Pubmed
Sall, Propofol at clinically relevant concentrations increases neuronal differentiation but is not toxic to hippocampal neural precursor cells in vitro. 2012, Pubmed
Sand, Isoflurane modulates activation and inactivation gating of the prokaryotic Na+ channel NaChBac. 2017, Pubmed
Stoetzer, Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine. 2016, Pubmed
Streiff, Saturation transfer difference nuclear magnetic resonance spectroscopy as a method for screening proteins for anesthetic binding. 2004, Pubmed
Sula, The complete structure of an activated open sodium channel. 2017, Pubmed
Tang, Large-scale molecular dynamics simulations of general anesthetic effects on the ion channel in the fully hydrated membrane: the implication of molecular mechanisms of general anesthesia. 2002, Pubmed
Tillman, Reversal of ion-charge selectivity renders the pentameric ligand-gated ion channel GLIC insensitive to anaesthetics. 2013, Pubmed , Xenbase
Venkitakrishnan, Use of NMR saturation transfer difference spectroscopy to study ligand binding to membrane proteins. 2012, Pubmed
Wagstaff, Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy. 2013, Pubmed
Webb, Comparative Protein Structure Modeling Using MODELLER. 2014, Pubmed
Webb, Protein structure modeling with MODELLER. 2014, Pubmed
Woll, Role for the propofol hydroxyl in anesthetic protein target molecular recognition. 2015, Pubmed , Xenbase
Yang, Electrophysiological Analysis of Voltage-Gated Ion Channel Modulation by General Anesthetics. 2018, Pubmed , Xenbase
Yang, Propofol inhibits prokaryotic voltage-gated Na+ channels by promoting activation-coupled inactivation. 2018, Pubmed
Zhang, Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel. 2012, Pubmed